We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Pfizer Should Update Label, Perform Meta-Analysis on Chantix
FDA: Pfizer Should Update Label, Perform Meta-Analysis on Chantix
June 24, 2011
The FDA is asking Pfizer to perform a meta-analysis of existing clinical data on Chantix to evaluate the drug’s cardiovascular safety after concerns that it may increase heart attack risk.